Author： Barman Balfour J.A. Goa K.L. Perry C.M.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.59, Iss.3, 2000-03, pp. : 511-518
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By III Thomas Q Garvey Hyman Paul E
Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. :
Access to resources
Recommend
Alosetron reintroduction debated
Inpharma, Vol. 1, Iss. 1356, 2002-01 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :
Alosetron: A Viewpoint by Douglas A. Drossman
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :